Freeman Technology relocates to larger premises

Published: 12-Sep-2011
Manufacturing Finance Analysis

New global hq includes manufacturing and office space and an applications laboratory

UK powder characterisation specialist Freeman Technology has relocated to larger premises in Tewkesbury, Gloucestershire after a continued period of growth.

The new 6,000ft2 global headquarters has been equipped to meet the company’s requirements for manufacturing and office space, as well as housing a 300ft2 applications laboratory.

The move into this ultra-modern facility comes just over a decade after the company launched its first powder testing instrument.

Operations director Tim Freeman said: ‘I am delighted to be able to report that demand for the FT4 powder rheometer continues to grow around the world and across powder processing industries.

‘As a result, not only are we building more systems, but we are also continuing to invest in r&d and applications development.

‘This new facility will enable us to scale up our manufacturing and r&d operations and continue to expand well into the future.’

He said the new laboratory would enable the company to carry out additional in-house research into powder behaviour and processing and provide more extensive applications support for customers.

Freeman Technology has enjoyed a continued period of growth and success. This year the company has not only added to its UK-based team but also expanded its global distribution network, with new partnerships covering Japan, India, Singapore, Malaysia, Thailand and Taiwan.

See more

You may also like

Analysis

Global biopharma faces talent shortages and regulatory uncertainty, Cytiva’s 2025 Global Biopharma Index finds

Read more
Cytiva’s latest Global Biopharma Index, surveying 1250 executives across 22 countries, reveals that while supply chain resilience is improving, talent shortages and policy instability are threatening growth across the biopharma sector

Trending Articles

  1. Agility, scale and trust: the outsourcing model driving pharma forward Outsourcing in the pharmaceutical industry has long been viewed as a matter of convenience and a way to ease short-term capacity pressures or delay the decision to invest in costly new facilities. That framing no longer fits
  2. RION engages Lonza to scale manufacturing exosome based therapeutics Collaboration leverages RION’s proprietary biomanufacturing process to propel RION’s industry-leading clinical development pipeline towards late-phase trials and commercialisation for multiple regenerative medical conditions
  3. Merck and others pull back from UK: what it means for pharma manufacturing With pharma giant Merck pulling its own version of Brexit, what can the UK do to retain its drug manufacturing capabilities?
  4. Genmab to acquire Merus in $8bn deal to expand late-stage pipeline The acquisition adds breakthrough therapy petosemtamab to Genmab’s portfolio, accelerating its shift to a wholly owned model and supporting multiple new drug launches by 2027
  5. Gerresheimer boosts Wertheim site with new production facility The new production hall will focus on RTF vials and innovative EZ-fill Smart packaging platform, with a total investment volume of around EUR €30 million

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

You may also like

Analysis

Global biopharma faces talent shortages and regulatory uncertainty, Cytiva’s 2025 Global Biopharma Index finds

Cytiva’s latest Global Biopharma Index, surveying 1250 executives across 22 countries, reveals that while supply chain resilience is improving, talent shortages and policy instability are threatening growth across the biopharma sector
Manufacturing

Rentschler Biopharma expands services in Japan and South Korea ahead of BioProcess International Asia

Rentschler Biopharma will showcase its Rentschler Expression Platform and Development Services at BioProcess International Asia in Kyoto, underscoring its commitment to supporting biopharma partners across Japan and South Korea
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Decoding your personal health ecosystem: the power of microbiome diagnostics and nutraceuticals

People often talk about a “gut instinct” or a “gut feeling.” Until recently, though, actually discussing digestive health might have seemed unusual, suggests Christina Casén, Senior Vice President, Clinical and Medical Affairs at Genetic Analysis AS
Manufacturing

Navigating SOE compliance: how to strengthen organic enforcement within your organisation

Part I of NSF’s webinar series explores strategies to meet rising regulatory demands, reduce fraud, and promote ethical practices
Manufacturing

Exploring Ireland’s thriving life sciences sector

NSF highlights its pivotal role in one of the world’s leading hubs for pharma and medical device manufacturing
Manufacturing

Quality control: the central pillar supporting peptide manufacturing

Amid the growing complexity and innovation in the field, this article explores how centralised quality control plays a pivotal role by ensuring both safety and consistency during custom peptide production
Manufacturing

Intertronics releases white paper on process validation for medical device bonding

The new guidance helps manufacturers cut costs, save time and ensure ISO and FDA compliance by designing out variability and improving process reliability from the start
Subscribe now